Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bayer Schering and EndoCeutics form global agreement for intravaginal DHEA

May 7, 2010

Cinacalcet allows lower doses of calcitriol and phosphate for X-linked hypophosphatemia

May 6, 2010

Synageva BioPharma files for orphan drug designation for SBC-102

May 6, 2010

Corcept updates Corlux program in Cushing's syndrome

May 6, 2010

Novel parathyroid hormone secretion inhibitors claimed by Amgen

May 6, 2010

FDA grants Osiris orphan drug designation for Prochymal in type 1 diabetes

May 5, 2010

K-V Pharmaceutical provides update on confirmatory trial of Gestiva

May 5, 2010

Repros receives guidance from FDA regarding clinical hold status of Proellex

May 4, 2010

EnzymeRx reports phase I results for pegsitacase

May 3, 2010

BioMarin plans phase III trial of GALNS in MPS IVA following phase I/II results

May 3, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...